Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P. Hughes, Dong‐Wook Kim, François-Xavier Mahon et al.|New England Journal of Medicine|2019Cited by 464
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcomeMartine E.D. Chamuleau, G.J. Ossenkoppele, Arjan A. van de Loosdrecht et al.|Haematologica|2008Cited by 99
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcomeMartine E.D. Chamuleau, G.J. Ossenkoppele, Arjan A. van de Loosdrecht et al.|Haematologica|2008Cited by 85
Clinical Impact of Polymerase Chain Reaction–Based <i>Aspergillus</i> and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter StudySammy Huygens, Bart Rijnders, Albert Dunbar et al.|Clinical Infectious Diseases|2023Cited by 57
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trialHjalmar Flygt, Ulla Olsson‐Strömberg, Stina Söderlund et al.|Leukemia|2024Cited by 13